Bridgebio Pharma, Inc. · NASDAQ:BBIO
The Vanguard Group reported a 8.68% stake in Bridgebio Pharma, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 8.68% stake in Bridgebio Pharma, Inc., 16,484,985 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 8.68%
- Shares
- 16,484,985
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 8.68% | 16,484,985 |
Source
Related
- Bridgebio Pharma, Inc.
- The Vanguard Group
- Bridgebio Pharma, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Aug 18, 2026
- Form 4 · Trimarchi Thomas · Aug 18, 2026
- Form 4 · Apuli Maricel · Aug 18, 2026